Israel’s largest healthcare provider reported a 94% drop in symptomatic Covid-19 infections among 600,000 people who received two doses of Pfizer’s vaccine in the country’s biggest study to date.

This webinar will share information on the influence of multimillion-dollar pharmaceutical costs, along with successful cost containment practices demonstrated through case studies of effective intervention.